IBDEI14E ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18173,0)
 ;;=E11.69^^61^805^32
 ;;^UTILITY(U,$J,358.3,18173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18173,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,18173,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,18173,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,18174,0)
 ;;=E11.8^^61^805^34
 ;;^UTILITY(U,$J,358.3,18174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18174,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,18174,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,18174,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,18175,0)
 ;;=E11.9^^61^805^35
 ;;^UTILITY(U,$J,358.3,18175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18175,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,18175,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18175,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18176,0)
 ;;=E11.29^^61^805^27
 ;;^UTILITY(U,$J,358.3,18176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18176,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,18176,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,18176,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,18177,0)
 ;;=E11.311^^61^805^14
 ;;^UTILITY(U,$J,358.3,18177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18177,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18177,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,18177,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,18178,0)
 ;;=E11.319^^61^805^15
 ;;^UTILITY(U,$J,358.3,18178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18178,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18178,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,18178,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,18179,0)
 ;;=E11.3211^^61^805^22
 ;;^UTILITY(U,$J,358.3,18179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18179,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,18179,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,18179,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,18180,0)
 ;;=E11.3212^^61^805^23
 ;;^UTILITY(U,$J,358.3,18180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18180,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,18180,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,18180,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,18181,0)
 ;;=E11.3213^^61^805^24
 ;;^UTILITY(U,$J,358.3,18181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18181,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,18181,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,18181,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,18182,0)
 ;;=E11.40^^61^805^10
 ;;^UTILITY(U,$J,358.3,18182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18182,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,18182,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,18182,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,18183,0)
 ;;=E11.51^^61^805^12
 ;;^UTILITY(U,$J,358.3,18183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18183,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,18183,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,18183,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,18184,0)
 ;;=E11.52^^61^805^11
 ;;^UTILITY(U,$J,358.3,18184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18184,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,18184,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,18184,2)
 ;;=^5002651
